BioPharm News

Feb 22, 2018
By BioPharm International Editors
The research partnership will focus on advancing regenerative medicine using porcine bioproducts.
Feb 22, 2018
By BioPharm International Editors
Avid Bioservices will provide commercial manufacture of an enzyme replacement therapy by Roivant Sciences' Enzyvant subsidiary.
Feb 22, 2018
By BioPharm International Editors
The new training center, the Jefferson Institute for Bioprocessing, will prepare engineering students and industry professionals for the field of biologics manufacturing.
Feb 22, 2018
By BioPharm International Editors
The company aims to add the additional analytical services in the European Union throughout 2018.
Feb 21, 2018
By BioPharm International Editors
The companies have partnered to develop and commercialize vectorized antibodies against tau for Alzheimer's and other neurodegenerative diseases.
Feb 21, 2018
By BioPharm International Editors
The agency released draft guidance on the format for electronic submissions of NDA and BLA content regarding the planning of bioresearch monitoring inspections.
Feb 20, 2018
By BioPharm International Editors
The company has entered into an agreement with an undisclosed partner to support the development and manufacture of a new biomanufacturing cell line.
Feb 20, 2018
By BioPharm International Editors
The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.
Feb 16, 2018
By BioPharm International Editors
The company has expanded its single-use manufacturing capabilities at its facility in Fermoy, Ireland.
Feb 15, 2018
By BioPharm International Editors
Fluarix Tetra has been approved for use in children aged six months and above.
native1_300x100
lorem ipsum